Press Releases

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update